blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4051698

EP4051698 - COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  05.08.2022
Database last updated on 15.06.2024
FormerThe international publication has been made
Status updated on  10.05.2021
Most recent event   Tooltip29.02.2024Supplementary search reportpublished on 27.03.2024  [2024/13]
Applicant(s)For all designated states
Decibel Therapeutics, Inc.
1325 Boylston Street, Suite 500
Boston, MA 02215 / US
For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
[2022/36]
Inventor(s)01 / BURNS, Joseph
1325 Boylston St Suite 500
Boston, MA 02215 / US
02 / ELLIS, Kathryn
1325 Boylston St Suite 500
Boston, MA 02215 / US
03 / GIBSON, Tyler
1325 Boylston St Suite 500
Boston, MA 02215 / US
04 / PALERMO, Adam
1325 Boylston St Suite 500
Boston, MA 02215 / US
05 / SCHWANDER, Martin
1325 Boylston St Suite 500
Boston, MA 02215 / US
06 / WHITTON, Jonathon
1325 Boylston St Suite 500
Boston, MA 02215 / US
07 / SABIN, Leah
C/o Regeneron Pharmaceuticals, Inc. 777 Old Saw
Mill River Road
Tarrytown, NY 10591 / US
08 / KYRATSOUS, Christos
C/o Regeneron Pharmaceuticals, Inc 777 Old Saw
Mill River Road
Tarrytown, NY 10591 / US
09 / DRUMMOND SAMUELSON, Meghan
C/o Regeneron Pharmaceuticals, Inc 777 Old Saw
Mill River Road
Tarrytown, NY 10591 / US
 [2022/36]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2022/36]
Application number, filing date20883297.230.10.2020
[2022/36]
WO2020US58265
Priority number, dateUS201962928290P30.10.2019         Original published format: US 201962928290 P
US202062965776P24.01.2020         Original published format: US 202062965776 P
US202062971504P07.02.2020         Original published format: US 202062971504 P
US202063023058P11.05.2020         Original published format: US 202063023058 P
[2022/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021087296
Date:06.05.2021
Language:EN
[2021/18]
Type: A1 Application with search report 
No.:EP4051698
Date:07.09.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 06.05.2021 takes the place of the publication of the European patent application.
[2022/36]
Search report(s)International search report - published on:US06.05.2021
(Supplementary) European search report - dispatched on:EP28.02.2024
ClassificationIPC:C07K14/47, C12N15/63, C12N15/86
[2022/36]
CPC:
C07K14/705 (EP,IL,KR); C12N15/86 (EP,IL,KR,US); A61K48/0075 (EP,IL,KR,US);
A61K48/005 (EP,IL,KR); A61P27/16 (KR); C07K14/4716 (EP,IL,KR,US);
A01K2217/075 (EP,IL); A01K2227/105 (EP,IL,US); A01K2267/0306 (EP,IL,US);
C12N2750/14143 (EP,IL,KR,US); C12N2800/40 (EP,IL,KR,US); C12N2830/008 (EP,IL,KR,US);
C12N2840/44 (EP,IL,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/36]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON SENSORINEURALEM HÖRVERLUST UNTER VERWENDUNG VON OTOFERLIN-DOPPELVEKTORSYSTEMEN[2022/36]
English:COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS[2022/36]
French:COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE LA SURDITÉ NEUROSENSORIELLE À L'AIDE DE SYSTÈMES À DEUX VECTEURS POUR L'OTOFERLINE[2022/36]
Entry into regional phase13.05.2022National basic fee paid 
13.05.2022Search fee paid 
13.05.2022Designation fee(s) paid 
13.05.2022Examination fee paid 
Examination procedure13.05.2022Examination requested  [2022/36]
19.12.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.10.2022Renewal fee patent year 03
27.10.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2017100791  (MASSACHUSETTS EYE & EAR INFIRMARY [US], et al) [A] 1-15 * Whole doc., in partic. p.16-19; claim 17 *;
 [IP]WO2019210181  (DECIBEL THERAPEUTICS INC [US]) [IP] 1-15* Whole doc., in partic. p.3, 16-22,29-30; Examples 1 and 2 *;
 [XP]US2020155705  (BURNS JOSEPH [US], et al) [XP] 1-15 * Whole doc., in partic. para. [0175,0178,0192-0205]; Seq. ID No.5 *;
 [A]  - E. CABERLOTTO ET AL, "Usher type 1G protein sans is a critical component of the tip-link complex, a structure controlling actin polymerization in stereocilia", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20110321), vol. 108, no. 14, doi:10.1073/pnas.1017114108, ISSN 0027-8424, pages 5825 - 5830, XP055647801 [A] 1-15 * p.5827, col.1, 1st para. in partic. *

DOI:   http://dx.doi.org/10.1073/pnas.1017114108
 [A]  - CABERLOTTO E. ET AL, "Usher type 1G protein sans is a critical component of the tip-link complex, a structure controlling actin polymerization in stereocilia; Supporting Information", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 108, no. 14, doi:10.1073/pnas.1017114108, ISSN 0027-8424, (20110405), pages 5825 - 5830, URL: https://www.pnas.org/highwire/filestream/605692/field_highwire_adjunct_files/0/pnas.201017114SI.pdf, XP055867195 [A] 1-15 * Fig. S1C in partic. *

DOI:   http://dx.doi.org/10.1073/pnas.1017114108
 [A]  - CORNS LAURA F. ET AL, "Mechanotransduction is required for establishing and maintaining mature inner hair cells and regulating efferent innervation", NATURE COMMUNICATIONS, UK, vol. 9, no. 1, doi:10.1038/s41467-018-06307-w, ISSN 2041-1723, (20181001), URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167318/pdf/41467_2018_Article_6307.pdf, XP093133183 [A] 1-15 * p.3, col.1 *

DOI:   http://dx.doi.org/10.1038/s41467-018-06307-w
International search[Y]WO2018039375  (AKOUOS INC [US], et al) [Y] 1-3, 29, 32, 33 * entire document *;
 [Y]WO2018204734  (UNIV FLORIDA [US], et al) [Y] 29, 32, 33 * entire document *;
 [A]WO2019165292  (AKOUOS INC [US], et al) [A] 1-3, 28-33* entire document *;
 [PX]WO2020163743  (DECIBEL THERAPEUTICS INC [US], et al) [PX] 1-3, 28-33 * entire document *;
 [Y]  - MICHALSKI et al., "Genetics of auditory mechano-electrical transduction", Pflugers Archives, (20140625), vol. 467, doi:10.1007/s00424-014-1552-9, pages 49 - 72, XP035416827 [Y] 1-3, 29, 32, 33 * . entire document *

DOI:   http://dx.doi.org/10.1007/s00424-014-1552-9
 [Y]  - SKARNES et al., "A conditional knockout resource for the genome-wide study of mouse gene function", Nature, (20110615), vol. 474, no. 7351, doi:10.1038/nature10163, pages 337 - 342, XP009157945 [Y] 3 * . entire document *

DOI:   http://dx.doi.org/10.1038/nature10163
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.